Loading resource…

Medical Department, St Mary’s Hospital, Lacor
The document outlines the local burden of heart failure, distinguishing HFREF and HFPEF phenotypes and their echocardiographic criteria. It evaluates the applicability of ESC/AHA guidelines in a low‑resource setting and proposes affordable medication regimens, including hydralazine‑ISDN, sacubitril‑valsartan, SGLT2 inhibitors, and beta‑blockers. Clinical decision flowcharts and mobile‑app concepts are presented to aid clinicians in tailoring therapy to patient phenotype, stability, and budget. The guide also highlights interdisciplinary collaboration, pharmacy‑led titration, and potential research directions for the region.
No account needed